A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children

Vaccine

Volumn 27, Issue 40, 2009, Pages 5472-5479

  Breiman, Robert F ^a   Brooks, W Abdullah ^a   Goswami, Doli ^a   Lagos, Rosanna ^b   Borja Tabora, Charissa ^c   Lanata, Claudio F ^d   Londoño, Jaime A Cèspedes ^e   Lum, Lucy Chai See ^f   Rappaport, Ruth ^g   Razmpour, Ahmad ^g   Walker, Robert E ^h   Gruber, William C ^g   Forrest, Bruce D ^g  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b HOSPITAL ROBERTO DEL RÍO   (Chile)

^c Manila Doctors Hospital   (Philippines)

^d INSTITUTO DE INVESTIGACIÓN NUTRICIONAL   (Peru)

^e FUNDACIÓN CARDIOINFANTIL INSTITUTO DE CARDIOLOGÍA   (Colombia)

^f UNIVERSITY OF MALAYA   (Malaysia)

^g WYETH RESEARCH   (United States)

^h MEDIMMUNE   (United States)

Author keywords

Children; Live attenuated influenza vaccine; Oral poliovirus vaccine

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; ORAL POLIOMYELITIS VACCINE;

ACUTE GASTROENTERITIS; ARTICLE; ASIA; BRONCHOSPASM; CHILD; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DECREASED APPETITE; DRUG SAFETY; DRUG TOLERABILITY; FEBRILE CONVULSION; FEMALE; FEVER; GASTRITIS; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE CONGESTION; PHYSICAL ACTIVITY; POLIOMYELITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINORRHEA; SIDE EFFECT; SOUTH AMERICA; STOMACH PAIN; TONSILLITIS; UPPER RESPIRATORY TRACT INFECTION; VIRUS STRAIN; VOMITING;

EID: 68449083036     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.07.002     Document Type: Article

References (39)

1. World Health Organization. H5N1 avian influenza: first steps towards development of a human vaccine. Wkly Epidemiol Rec 80 33 (2005) 277-278
2. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 57 RR-7 (2008) 1-60
3. Monto A.S., and Sullivan K.M. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 110 1 (1993) 145-160
4. Poehling K.A., Edwards K.M., Weinberg G.A., Szilagyi P., Staat M.A., Iwane M.K., et al. The underrecognized burden of influenza in young children. N Engl J Med 355 1 (2006) 31-40
5. Glezen W.P., and Couch R.B. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med 298 11 (1978) 587-592
6. Piedra P.A., Yan L., Kotloff K., Zangwill K., Bernstein D.I., King J., et al. Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children. Pediatrics 110 4 (2002) 662-672
7. Neuzil K.M., Zhu Y., Griffin M.R., Edwards K.M., Thompson J.M., Tollefson S.J., et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 185 2 (2002) 147-152
8. Centers for Disease Control and Prevention. Influenza vaccination coverage among children aged 6-59 months-six immunization information system sentinel sites, United States, 2006-07 influenza season. MMWR Morb Mortal Wkly Rep 56 37 (2007) 963-965
9. Centers for Disease Control and Prevention. State-specific influenza vaccination coverage among adults aged > or =18 years-United States, 2003-04 and 2005-06 influenza seasons. MMWR Morb Mortal Wkly Rep 56 37 (2007) 953-959
10. van Essen G.A., Palache A.M., Forleo E., and Fedson D.S. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 21 16 (2003) 1780-1785
11. FluMist® (Influenza Virus Vaccine Live, Intranasal). Full prescribing information (2007), MedImmune, Gaithersburg, MD
12. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 356 7 (2007) 685-696
13. Belshe R.B., Mendelman P.M., Treanor J., King J., Gruber W.C., Piedra P., et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 338 20 (1998) 1405-1412
14. Vesikari T., Fleming D.M., Aristegui J.F., Vertruyen A., Ashkenazi S., Rappaport R., et al. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics 118 6 (2006) 2298-2312
15. Tam J.S., Capeding M.R., Lum L.C., Chotpitayasunondh T., Jiang Z., Huang L.M., et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J 26 7 (2007) 619-628
16. Ashkenazi S., Vertruyen A., Aristegui J., Esposito S., McKeith D.D., Klemola T., et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 25 10 (2006) 870-879
17. Fleming D.M., Crovari P., Wahn U., Klemola T., Schlesinger Y., Langussis A., et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 25 10 (2006) 860-869
18. Simultaneous administration of multiple vaccines. In: Pickering L.K. (Ed). Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. (2006), American Academy of Pediatrics, Elk Grove Village, IL 34
19. American Academy of Pediatrics Committee on Infectious Diseases. Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. Pediatrics 99 2 (1997) 300-305
20. Nolan T., Lee M.S., Cordova J.M., Cho I., Walker R.E., August M.J., et al. Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities. Vaccine 21 11-12 (2003) 1224-1231
21. Pan American Health Organization. A culture of prevention: a model for control of vaccine-preventable diseases. Final report of the XVI meeting of the Technical Advisory Group on Vaccine-Preventable Diseases. Washington, DC: Pan American Health Organization; 2004.
22. Atkinson W.L., Pickering L.K., Schwartz B., Weniger B.G., Iskander J.K., and Watson J.C. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Recomm Rep 51 RR-2 (2002) 1-35
23. Kroger A.T., Atkinson W.L., Marcuse E.K., and Pickering L.K. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55 RR-15 (2006) 1-48
24. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2001-2002 season. Wkly Epidemiol Rec 76 8 (2001) 58-61
25. Centers for Disease Control and Prevention. The 1995-96 WHO Influenza Reagent Kit for the identification of influenza isolates (1995), WHO Collaborating Center for Surveillance, Epidemiology, and Control of Influenza, Centers for Disease Control and Prevention, Atlanta, GA
26. Belshe R.B., Gruber W.C., Mendelman P.M., Mehta H.B., Mahmood K., Reisinger K., et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis 181 3 (2000) 1133-1137
27. Belshe R.B., and Gruber W.C. Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatr Infect Dis J 19 5 suppl (2000) S66-71
28. Belshe R.B., Gruber W.C., Mendelman P.M., Cho I., Reisinger K., Block S.L., et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 136 2 (2000) 168-175
29. Edwards K.M., Dupont W.D., Westrich M.K., Plummer Jr. W.D., Palmer P.S., and Wright P.F. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 169 1 (1994) 68-76
30. Patriarca P.A., Wright P.F., and John T.J. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 13 5 (1991) 926-939
31. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine. Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. J Infect Dis 171 5 (1995) 1097-1106
32. Khalil M.K., al-Mazrou Y.Y., and al-Ghamdi Y.S. Vaccines: World Health Organization versus Federal Drug Administration recommended formula. East Mediterr Health J 6 4 (2000) 644-651
33. Giammanco G., De Grandi V., Lupo L., Mistretta A., Pignato S., Teuween D., et al. Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine. Eur J Epidemiol 4 1 (1988) 121-123
34. Vodopija I., Baklaic Z., Vlatkovic R., Bogaerts H., Delem A., and Andre F.E. Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain. Vaccine 4 4 (1986) 233-236
35. ICDDRB: Centre for Health and Population Research. Population-based influenza surveillance, Dhaka. Health Sci Bull 4 1 (2006) 1-5
36. Viboud C., Alonso W.J., and Simonsen L. Influenza in tropical regions. PLoS Med 3 4 (2006) e89
37. Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine 17 Suppl. 1 (1999) S3-S10
38. Mendelman P.M., Cordova J., Cho I., and Safety. efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults. Vaccine 19 17-19 (2001) 2221-2226
39. Bracco H., Farhat C.K., Tregnaghi M.W., Madhi S.A., Razmpour A., Palladino G., et al. Efficacy and safety of one and two doses of live attenuated influenza vaccine in vaccine-naive children. Pediatr Infect Dis J 28 (2009) 365-371